Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Stimulant vs. Non-Stimulant Treatment in ADHD
NCT02259517Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2014
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in attention deficit hyperactivity disorder (ADHD) comparing Guanfacine with Lisdexamfetamine (2 arms). Primary endpoint: Changes in Brain Segmentation Volume Produced by Stimulant or Non-stimulant Medications at 6 weeks. Started Sep 2014; status: terminated.
02
Drugs
lisdexamfetamineguanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02259517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259517.